This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Balaban M, Stancic V, Rincic G, Ledinsky M, Grbac L, Stancic N, Tomasic H.Recurrent venous thrombosis despite 'optimal anticoagulation therapy' for antiphospholipid syndrome - Could new oral anticoagulants solve the problem? Acta Clinica Croatica 49: 469-477, No. 4, Dec 2010 - Croatia
Cellulitis; adverse reactions; drug-induced; Methylprednisolone; Thrombophlebitis
An event is serious (FDA MedWatch definition) when the patient outcome is: death; life-threatening; hospitalisation; disability; congenital anomaly; requires intervention to prevent permanent impairment or damage
About this article
Cite this article
Methylprednisolone. React. Wkly. 1427, 32 (2012). https://doi.org/10.2165/00128415-201214270-00110
- Public Health
- Reaction Onset